Symmetry and Asymmetry in Medicinal Chemistry
A special issue of Symmetry (ISSN 2073-8994). This special issue belongs to the section "Chemistry: Symmetry/Asymmetry".
Deadline for manuscript submissions: 31 December 2025 | Viewed by 19336
Special Issue Editor
2. Regional Centre of Advanced Technologies and Materials, Palacky University, Olomouc, Czech Republic
Interests: medicinal chemistry; drug design; structure–activity relationships; pharmaceutical analysis; ADME; nanoparticles; nanoformulations; controlled/targeted delivery
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Symmetry, and, on the other hand, asymmetry (chirality), is one of the most important phenomena in nature, causing the uniqueness of life and life processes. Chirality is caused by a so-called chirality element in the structure of a molecule, which can be center (chiral atom), axis (with limited rotation around a simple bond), or plane. Any organism can be considered a chiral environment, and due to this phenomenon, it is possible to specifically influence the binding of biologically active compounds to their target sites, if their effect depends on the specific binding to the target organ.
The effect of diastereoisomers and even individual enantiomers can be completely different or even toxic. For this reason, in the last few decades, increased attention has been paid to the investigation of these optically active forms both in terms of binding to target sites and the detailed knowledge of the mechanism of action, including the structure of target sites and pharmacokinetic profile, i.e., bioavailability for target sites and affinity for metabolism at the formation of potentially toxic chiral metabolites.
This Special Issue “Symmetry and Asymmetry in Medicinal Chemistry” of the journal Symmetry will focus on recent activities in the investigation of bioactive compounds in all areas of medicinal chemistry. Therefore, we are looking for contributions (research and review articles) covering a wide range of topics on the asymmetry of bioactive compounds, including (though not limited to) the following:
- Asymmetric synthesis
- Chiral separation
- Analytical techniques suitable for the study of chiral compounds
- Structural characterization of receptors, enzymes, and other chiral targets of bioactive agents
- In silico study of chiral compounds
- In vitro/in vivo studies of chiral compounds
- Role of asymmetry in nanosciences
- Legislation and guidelines relating to the issue of chirality
Submit your paper and select the Journal “Symmetry” and the Special Issue “Symmetry and Asymmetry in Medicinal Chemistry” via: MDPI submission system. Our papers will be published on a rolling basis and we will be pleased to receive your submission once you have finished it.
Prof. Dr. Josef Jampilek
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Symmetry is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Chirality
- Drugs
- Natural compounds
- Synthesis
- Analysis
- Pharmacophore
- Targets
- In silico/in vitro/in vivo studies
- Asymmetry in nanosciences
- Legislation and guidelines
- Chemical biology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.